Quality-adjusted survival analysis of first-line treatment of hormone-receptor-positive HER2+ metastatic breast cancer with letrozole alone or in combination with lapatinib (Q85081364)
Jump to navigation
Jump to search
scientific article published on 12 October 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Quality-adjusted survival analysis of first-line treatment of hormone-receptor-positive HER2+ metastatic breast cancer with letrozole alone or in combination with lapatinib |
scientific article published on 12 October 2011 |
Statements
Quality-adjusted survival analysis of first-line treatment of hormone-receptor-positive HER2+ metastatic breast cancer with letrozole alone or in combination with lapatinib (English)
Beth Sherrill
Bintu Sherif
Mayur M Amonkar
Julie Maltzman
Lisa O'Rourke
Stephen Johnston
12 October 2011